{"id":"W2596456348","doi":"10.1007/s40262-017-0526-4","title":"Population Pharmacokinetic Analysis of Ixazomib, an Oral Proteasome Inhibitor, Including Data from the Phase III TOURMALINE-MM1 Study to Inform Labelling","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Takeda Oncology","keywords":"Ixazomib; Pharmacology; Proteasome inhibitor; Pharmacokinetics; Population; Chemistry; Medicine; Proteasome; Biochemistry; Carfilzomib","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002511542,0.0003462725,0.0006885927,0.0001096466,0.000552,0.0001865385,0.002445041,0.0001615788,0.000182278],"category_scores_gemma":[0.001063343,0.0002805502,0.0002276575,0.000349064,0.0001827334,0.00005687675,0.002006927,0.0004136649,0.00001330947],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001567027,"about_ca_system_score_gemma":0.00006943258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004228719,"about_ca_topic_score_gemma":0.0002979901,"domain_scores_codex":[0.9964421,0.0004189138,0.001369765,0.0008960503,0.000473343,0.0003997851],"domain_scores_gemma":[0.9957063,0.0001685742,0.0008061157,0.002700869,0.0002674241,0.0003507322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005371905,0.007996903,0.4369058,0.00006021249,0.006023349,0.00003549219,0.00124975,0.004593836,0.4076571,0.00002658624,0.005575105,0.124504],"study_design_scores_gemma":[0.04477341,0.007724928,0.3614576,0.0001671778,0.01483503,0.000004969278,0.001026149,0.1930799,0.3018449,0.0002118447,0.07224017,0.00263395],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952575,0.0001854339,0.001068633,0.0003637835,0.0006414944,0.0015128,0.000809413,0.0000289449,0.0001320116],"genre_scores_gemma":[0.9939662,0.0001471415,0.001173363,0.0008599235,0.001639989,0.00004454208,0.002043827,0.00004464608,0.00008042165],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1884861,"threshold_uncertainty_score":0.9999647,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.23345354210639,"score_gpt":0.4951004790580315,"score_spread":0.2616469369516415,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}